SLC22A1 and chronic myelogenous leukemia, BCR-ABL1 positive: Crossman et al. [101] analyzed the expression of the SLC22A1 gene in samples from CML patients before starting treatment and observed that the expression of SLC22A1 was variable and did not differ significantly from levels found in samples of bone marrow healthy individuals.